Clinical implication of PSA bounce after treatment of prostate cancer with brachytherapy and/or external beam radiotherapy with or without androgen deprivation

被引：1
|
作者：
Antonucci, JV [1 ]
Fitch, DL [1 ]
Vargas, CE [1 ]
Boike, T [1 ]
Byrd, C [1 ]
Gustafson, GS [1 ]
Martinez, AA [1 ]
Vicini, FA [1 ]
Kestin, LL [1 ]
机构：
[1] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48072 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2122
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [21] Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer
    Kunimitsu Kanai
    Jun Nakashima
    Akitomo Sugawara
    Naoyuki Shigematsu
    Hirohiko Nagata
    Eiji Kikuchi
    Akira Miyajima
    Ken Nakagawa
    Atsushi Kubo
    Mototsugu Oya
    International Journal of Clinical Oncology, 2009, 14 : 502 - 506
  • [22] HDR BRACHYTHERAPY OF PROSTATE CANCER AS A BOOST AFTER EXTERNAL BEAM RADIOTHERAPY
    Kanikowski, M.
    Skowronek, J.
    Kubaszewska, M.
    Chichel, A.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S324 - S324
  • [23] The PSA 'bounce' phenomena after external beam radiation for clinically localized prostate cancer.
    Rosser, CJ
    Kuban, DA
    Levy, LB
    Chichakli, R
    Pollack, A
    Lee, A
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 167 (04): : 391 - 391
  • [24] Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer
    Buyyounouski, MK
    Hanlon, AL
    Eisenberg, DF
    Horwitz, EM
    Feigenberg, SJ
    Uzzo, RG
    Pollack, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05): : 1455 - 1462
  • [25] Additional androgen deprivation makes the difference Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapy
    Schiffmann, Jonas
    Lesmana, Hans
    Tennstedt, Pierre
    Beyer, Burkhard
    Boehm, Katharina
    Platz, Volker
    Tilki, Derya
    Salomon, Georg
    Petersen, Cordula
    Kruell, Andreas
    Graefen, Markus
    Schwarz, Rudolf
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (04) : 330 - 337
  • [26] NADIR PSA and time to NADIR PSA after radiotherapy +/- androgen deprivation as a predictor of prostate cancer outcome.
    Sancho Pardo, G.
    GAmez de Segura, G.
    Gich, I.
    FarrA, N.
    Membrive, I.
    Trilla, J.
    RosellA, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S451 - S452
  • [27] HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY WITHOUT ANDROGEN DEPRIVATION FOR INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY RESULTS AND TOXICITY ANALYSIS
    Dal Pra, A.
    Faria, S.
    Cury, F.
    David, M.
    Duclos, M.
    Shenouda, G.
    Souhami, L.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S46 - S46
  • [28] A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL is clinically significant after external beam radiotherapy for prostate cancer
    Feigenberg, Steven J.
    Hanlon, Alexandra L.
    Horwitz, Eric M.
    Uzzo, Robert G.
    Eisenberg, Debra
    Pollack, Alan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (05): : 458 - 462
  • [29] PSA bounces after brachytherapy HDR and external beam radiation therapy for prostate cancer
    Makarewicz, Roman
    Roszkowski, Krzysztof
    Lebioda, Andrzej
    Reszke, Joanna
    Ziolkowska, Ewa
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2006, 11 (05) : 217 - 222
  • [30] External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer
    Strom, Tobin J.
    Hutchinson, Sean Z.
    Shrinath, Kushagra
    Cruz, Alex A.
    Figura, Nicholas B.
    Nethers, Kevin
    Biagioli, Matthew C.
    Fernandez, Daniel C.
    Heysek, Randy V.
    Wilder, Richard B.
    INTERNATIONAL BRAZ J UROL, 2014, 40 (04): : 474 - 483
12345